(Q33760201)

29 July 2017

1 reference

title

HIV infection and pathogenesis: what about chemokines? (English)

1 reference

29 July 2017

0 references

0 references

1

Gallo RC

1 reference

29 July 2017

Garzino-Demo A

2

1 reference

29 July 2017

DeVico AL

series ordinal

3

1 reference

29 July 2017

publication date

1 September 1999

1 reference

Journal of Clinical Immunology

29 July 2017

published in

1 reference

29 July 2017

volume

19

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

293-299

1 reference

Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor.

29 July 2017

cites work

1 reference

12 December 2020

Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry

1 reference

12 December 2020

The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression

1 reference

12 December 2020

Effect of immunization with an inactivated gp120-depleted HIV-1 immunogen on beta-chemokine and cytokine production in subjects with HIV-1 infection

1 reference

12 December 2020

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

1 reference

12 December 2020

Correlation between plasma levels of cytokines and HIV-1 RNA copy number in HIV-infected patients

1 reference

12 December 2020

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

1 reference

12 December 2020

Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage.

1 reference

12 December 2020

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

1 reference

12 December 2020

beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques

1 reference

12 December 2020

Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans

1 reference

12 December 2020

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

12 December 2020

CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).

1 reference

12 December 2020

Concentrations of circulating beta-chemokines do not correlate with viral load in human immunodeficiency virus-infected individuals

1 reference

12 December 2020

In vitro p24 antigen-stimulated lymphocyte proliferation and beta-chemokine production in human immunodeficiency virus type 1 (HIV-1)-seropositive subjects after immunization with an inactivated gp120-depleted HIV-1 immunogen (Remune)

1 reference

12 December 2020

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

1 reference

12 December 2020

Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission

1 reference

12 December 2020

Lack of associations of chemotactic cytokines with viral burden, disease progression, or lymphocyte subsets in HIV-infected individuals

1 reference

12 December 2020

Serum levels of RANTES and MIP-1 alpha in HIV-positive long-term survivors and progressor patients

1 reference

12 December 2020

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

1 reference

12 December 2020

CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity.

1 reference

12 December 2020

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

12 December 2020

The inhibitory effect of RANTES on the infection of primary macrophages by R5 human immunodeficiency virus type-1 depends on the macrophage activation state

1 reference

12 December 2020

Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection

1 reference

12 December 2020

Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression

1 reference

12 December 2020

Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1alpha and RANTES correlate with virus load in human immunodeficiency virus infection

1 reference

12 December 2020

Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV.

1 reference

12 December 2020

Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils

1 reference

12 December 2020

Generation of CD8 suppressor factor and beta chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques

1 reference

12 December 2020

Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro

1 reference

12 December 2020

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

1 reference

12 December 2020

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

12 December 2020

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

12 December 2020

Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction

1 reference

12 December 2020

Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans.

1 reference

12 December 2020

Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele

1 reference

12 December 2020

A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor

1 reference

12 December 2020

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

1 reference

12 December 2020

Increased intracellular accumulation of macrophage inflammatory protein 1beta and its decreased secretion correlate with advanced HIV disease.

1 reference

12 December 2020

Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines

1 reference

12 December 2020

Beta-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge

1 reference

12 December 2020

Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines

1 reference

12 December 2020

Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques

1 reference

12 December 2020

Chemokine and chemokine receptor mRNA expression in human platelets

1 reference

12 December 2020

Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes

1 reference

12 December 2020

A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signaling

1 reference

12 December 2020

Protective mucosal immunity elicited by targeted lymph node immunization with a subunit SIV envelope and core vaccine in macaques

1 reference

12 December 2020

C-C chemokines, pivotal in protection against HIV type 1 infection

1 reference

12 December 2020

Serum chemokine levels in patients with non-progressing HIV infection

1 reference

12 December 2020

Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1beta are associated with a decreased risk of HIV disease progression

1 reference

12 December 2020

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

12 December 2020

Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection.

1 reference

12 December 2020

A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection

1 reference

12 December 2020

Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk

1 reference

12 December 2020

Chemokines in stored platelet concentrates

1 reference

12 December 2020

Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.

1 reference

12 December 2020

Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status

1 reference

12 December 2020

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

12 December 2020

Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection

1 reference

12 December 2020

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

12 December 2020

Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion

1 reference

12 December 2020

Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.

1 reference

12 December 2020

Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage

1 reference

12 December 2020

Massive expansion of antigen-specific CD8+ T cells during an acute virus infection

1 reference

12 December 2020

CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction

1 reference

12 December 2020

LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity

1 reference

12 December 2020

Inhibition of HIV-1 infection by the beta-chemokine MDC

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1020539524373

1 reference

Dimensions Publication ID

29 July 2017

1050775099

0 references

1 reference